Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
6 papers
Recent·Most cited
A. A. Cohen, N. A. van Doremalen, A. J. Greaney…·P. J. Bjorkman
This study designs mosaic RBD nanoparticles to elicit antibodies against conserved sarbecovirus epitopes, showing broader protection against SARS-CoV-2 variants and animal sarbecoviruses in animal models.
C. O. Barnes, T. Schoofs, P. N. P. Gnanapragasam…·P. J. Bjorkman
This paper describes a VRC01-class antibody with lower somatic mutation but comparable breadth and potency to other broadly neutralizing antibodies against HIV-1.
S. Tanaka, C. A. Olson, C. O. Barnes…·P. Soon-Shiong
This study uses mRNA display to identify and engineer neutralizing antibodies against SARS-CoV-2 variants, revealing binding modes and demonstrating their effectiveness against mutations in the spike protein.
C. A. Jette, A. A. Cohen, P. N. P. Gnanapragasam…·C. O. Barnes
The paper identifies two class 4 anti-RBD antibodies from COVID-19 donors that broadly neutralize zoonotic sarbecoviruses and SARS-CoV-2 variants with high potency.
A. A. Cohen, P. N. P. Gnanapragasam, Y. E. Lee…·P. J. Bjorkman
The paper demonstrates that mosaic nanoparticles displaying multiple coronavirus RBDs induce cross-reactive and neutralizing antibodies against SARS-CoV-2 and zoonotic coronaviruses in mice.
M. S. Ladinsky, P. N. P. Gnanapragasam, Z. Yang…·P. J. Bjorkman
The paper uses fusion inhibitors to trap HIV-1 in a pre-hairpin intermediate state and visualizes it via electron tomography, revealing the structure of Env-mediated fusion.